Trial intelligence / Profile preview

Propranolol for emotional memory re-experiencing in post-traumatic stress disorder

2006-006386-16Phase 3Terminated

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in post-traumatic stress disorder (PTSD) comparing Propranolol with Placebo (2 arms). Primary endpoint: Amygdala activation during traumatic memory recall. Started Mar 2008; status: terminated.

02

Drugs

propranolol
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on 2006-006386-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006386-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call